MoneyWorks4Me

Transgene Biotek - Quaterly Results

10 Aug 2024 Evaluate
A decrease of about -51.00% in the sales to Rs. 0.49 millions was observed for the quarter ended June 2024. The sales stood at Rs. 1.00 millions during the similar quarter previous year.The Total Profit for the quarter ended June 2024 of Rs. 2.00 millions grew from Rs.-1.31 millions Operating profit Margin for the quarter ended June 2024 improved to 2.40% as compared to -0.76% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 0.49 1.00 -51.00 0.49 1.00 -51.00 2.35 0.55 327.27
Other Income 6.52 0.44 1381.82 6.52 0.44 1381.82 1.83 1.75 4.57
PBIDT 2.40 -0.76 -415.79 2.40 -0.76 -415.79 -4.34 -8.77 -50.51
Interest 0.17 0.32 -46.88 0.17 0.32 -46.88 1.29 1.81 -28.73
PBDT 2.23 -1.08 -306.48 2.23 -1.08 -306.48 -5.63 -10.58 -46.79
Depreciation 0.23 0.23 0.00 0.23 0.23 0.00 0.92 49.50 -98.14
PBT 2.00 -1.31 -252.67 2.00 -1.31 -252.67 -6.55 -60.08 -89.10
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 2.00 -1.31 -252.67 2.00 -1.31 -252.67 -6.55 -60.08 -89.10
Equity 757.70 757.70 0.00 757.70 757.70 0.00 757.70 757.70 0.00
PBIDTM(%) 489.80 -76.00 -744.47 489.80 -76.00 -744.47 -184.68 -1594.55 -88.42
Peers
Company Name CMP
Sagility 45.15
Knowledge RealtyTrt. 113.28
Prime Focus 310.60
Indegene 578.05
Syngene Internatl. 382.65
View more..